Cannabis researcher to study head trauma treatment

8/4/14–KannaLife Sciences Inc., case a pharmaceutical cannabis research and development company headquartered in Lloyd Harbor, for sale signed its second license agreement with the National Institutes of Health Monday to research treatments for a neurodegenerative disease linked to head trauma. Read